全文获取类型
收费全文 | 407篇 |
免费 | 21篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 19篇 |
妇产科学 | 8篇 |
基础医学 | 66篇 |
口腔科学 | 13篇 |
临床医学 | 44篇 |
内科学 | 54篇 |
皮肤病学 | 5篇 |
神经病学 | 17篇 |
特种医学 | 55篇 |
外科学 | 46篇 |
综合类 | 17篇 |
预防医学 | 35篇 |
药学 | 30篇 |
肿瘤学 | 20篇 |
出版年
2022年 | 4篇 |
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 9篇 |
2017年 | 8篇 |
2016年 | 9篇 |
2015年 | 8篇 |
2014年 | 8篇 |
2013年 | 20篇 |
2012年 | 25篇 |
2011年 | 26篇 |
2010年 | 14篇 |
2009年 | 18篇 |
2008年 | 21篇 |
2007年 | 9篇 |
2006年 | 15篇 |
2005年 | 8篇 |
2004年 | 5篇 |
2003年 | 7篇 |
2002年 | 9篇 |
2001年 | 7篇 |
2000年 | 8篇 |
1999年 | 7篇 |
1998年 | 20篇 |
1997年 | 15篇 |
1996年 | 12篇 |
1995年 | 8篇 |
1994年 | 11篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 8篇 |
1989年 | 10篇 |
1988年 | 8篇 |
1987年 | 14篇 |
1986年 | 6篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1967年 | 3篇 |
1896年 | 1篇 |
排序方式: 共有431条查询结果,搜索用时 15 毫秒
61.
62.
Percutaneous cholecystostomy: an alternative to surgical cholecystostomy for acute cholecystitis? 总被引:1,自引:0,他引:1
Emergency percutaneous cholecystostomy was successfully performed in 39 of 40 attempted procedures in 37 hospitalized patients with possible acute cholecystitis. All cholecystostomies were performed with ultrasound guidance and preferentially with the transhepatic route, and all but four were performed at the patient's bedside. The patients had been hospitalized an average of 27 days before the procedure. Twenty-two of the 37 patients (59%) eventually died during hospitalization because of other medical or surgical problems. Only minor complications related to percutaneous cholecystostomy placement occurred in this series: catheter dislodgment without sequelae (n = 2) and significant abdominal pain (n = 2). Technical problems included guide-wire buckling during catheter insertion (n = 1) and failed attempted cholecystostomy (n = 1). Percutaneous cholecystostomy is a safe alternative to surgical cholecystostomy in the treatment of patients suspected of having acute cholecystitis. 相似文献
63.
Objective: To define the lowest effective dose of botulinum toxin type A (Dysport®) and safety in the treatment of adult patients with upper limb spasticity.Design: This was a prospective, randomized, double-blind, dose-ranging study. Patients received either a placebo or one of three doses of Dysport® (350, 500, 1000?U) into five muscles of affected arm by anatomical and electromyography guidance. Efficacy was assessed periodically throughout the 6-month study period by the Modified Ashworth Scale (MAS), the Action Research Arm Test (ARA), the Barthel Index (BI) and the Visual Analogue Pain Scale (VAS).Results: Fifty patients were recruited. The four study groups were comparable at baseline with respect to their demographical characteristics and severity of spasticity. All doses of Dysport® studied showed a significant reduction from baseline of muscle tone and pain compared to placebo. However, the effect of functional disability was best at a dose of 500?U and the peak improvement was at week 8 after injection. A dose of 1000?U Dysport produced such an excess degree of muscle weakening that the number of randomized patients was reduced to five. BI and ARA of all patients were decrease after injection. No other adverse event was considered related to the study medication.Conclusion: This study suggests that treatment with Dysport® reduces muscle tone in adult patients with upper limb spasticity. The optimal dose for treatment of patients with residual voluntary movement in the upper limb appears to be 500?U. 相似文献
64.
65.
Hans Ehrsson Staffan Eksborg Anders Österborg Håkan Mellstedt Astrid Lindfors 《Medical oncology (Northwood, London, England)》1989,6(2):151-154
The pharmacokinetics of melphalan have been studied after oral doses of 5,10 and 20 mg, and 10 mg i.v. Seven patients with multiple myeloma received the drug on 4 consecutive days and the concentration of melphalan was determined by liquid chromatography. Melphalan was rapidly absorbed after p.o. administration. Absorption lag-time was less than 1 h. The median time for attaining the peak concentration was 1.12 h (97% confidence interval: 0.68–1.55), 1.21 h (0.85–1.43) and 1.08 h (0.84–1.29) after doses of 5,10 and 20 mg. The bioavailability showed large interindividual variations, and was not significantly affected by the dose given. There was a significant decrease in bioavailability during the treatment course (P < 0.05). Absorption of melphalan obeys first-order kinetics in the dose interval studied. The results indicate that it might be of benefit to administrate oral melphalan for fewer days than the usually used 4 day regimen, in an attempt to achieve a higher bioavailability. 相似文献
66.
67.
68.
Claes Andersson Marcus Bendtsen Petra Lindfors Olof Molander Philip Lindner Naira Topooco Karin Engstrm Anne H. Berman 《International journal of methods in psychiatric research》2021,30(4)
ObjectivesThis study evaluates whether initiation rates, completion rates, response patterns and prevalence of psychiatric conditions differ by level of personal integrity information given to prospective participants in an online mental health self‐report survey.MethodsA three‐arm, parallel‐group, single‐blind experiment was conducted among students from two Swedish universities. Consenting participants following e‐mail invitation answered the World Health Organization (WHO) World Mental Health‐International College Student (WMH‐ICS) mental health self‐report survey, screening for eight psychiatric conditions. Random allocation meant consenting to respond (1) anonymously; (2) confidentially, or (3) confidentially, where the respondent also gave consent for collection of register data.ResultsNo evidence was found for overall between‐group differences with respect to (1) pressing a hyperlink to the survey in the invitation email; and (2) abandoning the questionnaire before completion. However, participation consent and self‐reported depression were in the direction of higher levels for the anonymous group compared to the two confidential groups.ConclusionsConsent to participate is marginally affected by different levels of personal integrity information. Current standard participant information procedures may not engage participants to read the information thoroughly, and online self‐report mental health surveys may reduce stigma and thus be less subject to social desirability bias. 相似文献
69.
Lindfors K Suzuki H Novak J Collin P Saavalainen P Koskinen LL Mäki M Kaukinen K 《Journal of clinical immunology》2011,31(1):74-79
In celiac disease, gluten ingestion provokes small-bowel mucosal injury and production of IgA autoantibodies against transglutaminase
2 (TG2). It has been suggested that in celiac patients IgA could mediate the transepithelial passage of gluten peptides in
a mechanism involving the transferrin receptor. As IgA1 with galactose-deficient O-linked glycans has elevated affinity for the transferrin receptor, we assessed whether total serum IgA1 and IgA1 anti-TG2
autoantibodies in celiac patients are aberrantly glycosylated. We report that males with celiac disease have higher total
serum levels of galactose-deficient IgA1 than non-celiac males. Furthermore, O-glycans of the disease-specific TG2 IgA1 autoantibodies in celiac patients exhibited elevated galactose deficiency. A gluten-free
diet had no effect on the total serum levels of galactose-deficient IgA1, whereas the amount of galactose-deficient anti-TG2
IgA1 decreased. Thus, the undergalactosylated IgA1 molecules are not pathognomonic for celiac disease, but galactose deficiency
in IgA1 could be an aggravating factor. 相似文献
70.
Pia Svedberg Lisa Mather Gunnar Bergström Petra Lindfors Victoria Blom 《International journal of behavioral medicine》2018,25(1):103-111